| Literature DB >> 29803932 |
Atheer Awad1, Sarah J Trenfield1, Alvaro Goyanes2, Simon Gaisford3, Abdul W Basit4.
Abstract
The pharmaceutical industry stands on the brink of a revolution, calling for the recognition and embracement of novel techniques. 3D printing (3DP) is forecast to reshape the way in which drugs are designed, manufactured, and used. Although a clear trend towards personalised fabrication is perceived, here we accentuate the merits and shortcomings of each technology, providing insights into aspects such as the efficiency of production, global supply, and logistics. Contemporary opportunities for 3DP in drug discovery and pharmaceutical development and manufacturing are unveiled, offering a forward-looking view on its potential uses as a digitised tool for personalised dispensing of drugs.Mesh:
Substances:
Year: 2018 PMID: 29803932 DOI: 10.1016/j.drudis.2018.05.025
Source DB: PubMed Journal: Drug Discov Today ISSN: 1359-6446 Impact factor: 7.851